A novel use of recombinant factor VIIa in HELLP syndrome associated with spontaneous hepatic rupture and abdominal compartment syndrome

被引：33
作者：
Dart, BW
Cockerham, WT
Torres, C
Kipikasa, JH
Maxwell, RA
机构：
[1] Univ Tennessee, Coll Med, Dept Surg, Div Surg Crit Care, Chattanooga, TN 37403 USA
[2] Univ Tennessee, Coll Med, Dept Obstet & Gynecol, Chattanooga, TN 37403 USA
来源：
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE | 2004年 / 57卷 / 01期
关键词：
D O I：
10.1097/01.TA.0000135142.80368.65
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
[No abstract available]
引用
收藏
页码：171 / 174
页数：4
相关论文
共 29 条
[1]   Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven®) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery [J].
Al Douri, M ;
Shafi, T ;
Al Khudairi, D ;
Al Bokhari, E ;
Black, L ;
Akinwale, N ;
Musa, MO ;
Al Homaidhi, A ;
Al Fagih, M ;
Andreasen, RB .
BLOOD COAGULATION & FIBRINOLYSIS, 2000, 11 :S121-S127
[2]   HEPATIC HISTOPATHOLOGIC CONDITION DOES NOT CORRELATE WITH LABORATORY ABNORMALITIES IN HELLP SYNDROME (HEMOLYSIS, ELEVATED LIVER-ENZYMES, AND LOW PLATELET COUNT) [J].
BARTON, JR ;
RIELY, CA ;
ADAMEC, TA ;
SHANKLIN, DR ;
KHOURY, AD ;
SIBAI, BM .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1992, 167 (06) :1538-1543
[3]   Recombinant activated factor VII in children with acute bleeding resulting from liver failure and disseminated intravascular coagulation [J].
Chuansumrit, A ;
Chantarojanasiri, T ;
Isarangkura, P ;
Teeraratkul, S ;
Hongeng, S ;
Hathirat, P .
BLOOD COAGULATION & FIBRINOLYSIS, 2000, 11 :S101-S105
[4]   ACUTE LIVER NECROSIS IN THE HELLP SYNDROME - SUCCESSFUL OUTCOME AFTER ORTHOTOPIC LIVER-TRANSPLANTATION - A CASE-REPORT [J].
ERHARD, J ;
LANGE, R ;
NIEBEL, W ;
SCHERER, R ;
KOX, WJ ;
PHILIPP, T ;
EIGLER, FW .
TRANSPLANT INTERNATIONAL, 1993, 6 (03) :179-181
[5]   Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy:: a double-blind placebo-controlled andomised trial [J].
Friederich, PW ;
Herny, CP ;
Messelink, EJ ;
Geerdink, MG ;
Keller, T ;
Kurth, KH ;
Büller, HR ;
Levi, M .
LANCET, 2003, 361 (9353) :201-205
[6]  
HEDNER U, 1988, LANCET, V2, P1193
[7]   Recombinant coagulation factor VIIa: From the concept to clinical application in hemophilia treatment in 2000 [J].
Hedner, U .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2000, 26 (04) :363-366
[8]   Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation - A pilot study [J].
Hendriks, HGD ;
Meijer, K ;
de Wolf, JTM ;
Klompmaker, IJ ;
Porte, RJ ;
de Kam, PJ ;
Hagenaars, AJM ;
Melsen, T ;
Slooff, MJH ;
van der Meer, J .
TRANSPLANTATION, 2001, 71 (03) :402-405
[9]   The use of recombinant factor VIIA (rFVIIA) in laparoscopic liver biopsy (LB): A pilot trial [J].
Jeffers, LJ ;
Bernstein, DE ;
Erhardsten, E ;
Acebo, W ;
Reddy, KR ;
Bech, RM ;
Schiff, ER .
GASTROENTEROLOGY, 1998, 114 (04) :A1264-A1265
[10]   Treatment of traumatic bleeding with recombinant factor VIIa [J].
Kenet, G ;
Walden, R ;
Eldad, A ;
Martinowitz, U .
LANCET, 1999, 354 (9193) :1879-1879
123